BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35743062)

  • 1. Coronin1C Is a GDP-Specific Rab44 Effector That Controls Osteoclast Formation by Regulating Cell Motility in Macrophages.
    Yamaguchi Y; Kadowaki T; Aibara N; Ohyama K; Okamoto K; Sakai E; Tsukuba T
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rab44, a novel large Rab GTPase, negatively regulates osteoclast differentiation by modulating intracellular calcium levels followed by NFATc1 activation.
    Yamaguchi Y; Sakai E; Okamoto K; Kajiya H; Okabe K; Naito M; Kadowaki T; Tsukuba T
    Cell Mol Life Sci; 2018 Jan; 75(1):33-48. PubMed ID: 28791425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin binding LIM 1 (abLIM1) negatively controls osteoclastogenesis by regulating cell migration and fusion.
    Narahara H; Sakai E; Yamaguchi Y; Narahara S; Iwatake M; Okamoto K; Yoshida N; Tsukuba T
    J Cell Physiol; 2018 Jan; 234(1):486-499. PubMed ID: 29904924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and localisation of Rab44 in immune-related cells change during cell differentiation and stimulation.
    Tokuhisa M; Kadowaki T; Ogawa K; Yamaguchi Y; Kido MA; Gao W; Umeda M; Tsukuba T
    Sci Rep; 2020 Jul; 10(1):10728. PubMed ID: 32612275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abr, a Rho-regulating protein, modulates osteoclastogenesis by enhancing lamellipodia formation by interacting with poly(ADP-ribose) glycohydrolase.
    Farhana F; Sakai E; Koyanagi Y; Yamaguchi Y; Alam MI; Okamoto K; Tsukuba T
    Mol Biol Rep; 2023 Sep; 50(9):7557-7569. PubMed ID: 37507586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
    Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
    Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rab34 plays a critical role as a bidirectional regulator of osteoclastogenesis.
    Feng Y; Tran MT; Lu Y; Htike K; Okusha Y; Sogawa C; Eguchi T; Kadowaki T; Sakai E; Tsukuba T; Okamoto K
    Cell Biochem Funct; 2022 Apr; 40(3):263-277. PubMed ID: 35285960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rab44 negatively regulates myoblast differentiation by controlling fusogenic protein transport and mTORC1 signaling.
    Tanimoto A; Yamaguchi Y; Kadowaki T; Sakai E; Oyakawa S; Ono Y; Yoshida N; Tsukuba T
    J Cell Biochem; 2023 Oct; 124(10):1486-1502. PubMed ID: 37566644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.
    Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y
    J Biol Chem; 2012 Jun; 287(23):19229-41. PubMed ID: 22500026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rab44 Deficiency Induces Impaired Immune Responses to Nickel Allergy.
    Noguromi M; Yamaguchi Y; Sato K; Oyakawa S; Okamoto K; Murata H; Tsukuba T; Kadowaki T
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
    Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
    Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH3P2 suppresses osteoclast differentiation through restricting membrane localization of myosin 1E.
    Nakamura S; Masuyama R; Sakai K; Fukuda K; Takeda K; Tanimura S
    Genes Cells; 2020 Nov; 25(11):707-717. PubMed ID: 32916757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2.
    Dong Y; Song C; Wang Y; Lei Z; Xu F; Guan H; Chen A; Li F
    Cell Signal; 2017 Jun; 34():55-65. PubMed ID: 28302565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
    Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The actin binding protein adseverin regulates osteoclastogenesis.
    Hassanpour S; Jiang H; Wang Y; Kuiper JW; Glogauer M
    PLoS One; 2014; 9(9):e109078. PubMed ID: 25275604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility.
    Jin SH; Kim H; Gu DR; Park KH; Lee YR; Choi Y; Lee SH
    BMB Rep; 2018 Jul; 51(7):356-361. PubMed ID: 29921413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spi-C positively regulates RANKL-mediated osteoclast differentiation and function.
    Go EM; Oh JH; Park JH; Lee SY; Lee NK
    Exp Mol Med; 2020 Apr; 52(4):691-701. PubMed ID: 32341419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.
    Yang DQ; Feng S; Chen W; Zhao H; Paulson C; Li YP
    J Bone Miner Res; 2012 Aug; 27(8):1695-707. PubMed ID: 22467241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.
    Cheng S; Zhao SL; Nelson B; Kesavan C; Qin X; Wergedal J; Mohan S; Xing W
    PLoS One; 2012; 7(3):e32887. PubMed ID: 22403721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulators of osteoclast differentiation and cell-cell fusion.
    Miyamoto T
    Keio J Med; 2011; 60(4):101-5. PubMed ID: 22200633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.